Vitrakvi (larotrectinib) - Bayer
Augtyro (repotrectinib) - BMS
Rozlytrek (entrectinib) - Roche
Braftovi (encorafenib) - Pfizer
Tafinlar (dabrafenib) - Novartis
Mektovi (binimetinib) - Pfizer
Gavreto (pralsetinib) - Rigel Pharmaceuticals
Retevmo (selpercatinib) - Eli Lilly
Mekinist (trametinib) - Novartis, BeOne Medicines
Precision Thyroid Oncology Using Genetic-Based Therapies: A Narrative Review. (PubMed, Thyroid) - Oct 21, 2026 - "Precision oncology is increasingly being integrated into the management of advanced thyroid cancer. However, its impact varies widely across different tumor settings, and its real-world use is strongly influenced by country-specific drug regulations." 
Journal • Oncology • Solid Tumor • Thyroid Gland Anaplastic Carcinoma • Thyroid Gland Carcinoma • Thyroid Gland Medullary Carcinoma • NTRK • RET
http://www.ncbi.nlm.nih.gov/pubmed/42897968
 
Mario Vitale; Mingzhao Xing; Vincenzo Marotta
 
Oct 21, 2026
 
Prev Next